Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 02, 2023

BUY
$191.51 - $216.16 $1.06 Million - $1.19 Million
5,511 Added 179.51%
8,581 $849 Million
Q2 2023

Jul 24, 2023

BUY
$187.64 - $206.25 $576,054 - $633,187
3,070 New
3,070 $591 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Mrp Capital Investments, LLC Portfolio

Follow Mrp Capital Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mrp Capital Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mrp Capital Investments, LLC with notifications on news.